FDA Delays Novavax Approval

News

FDA Just Approved a New Covid Vaccine

FDA Approves Novavax COVID Vaccine With Restricted Use

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from COVID can also get the shot.

· 16d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

· 20h · on MSN

FDA grants limited approval to new Covid vaccine from Moderna

Medical Xpress15d

FDA gives full approval to Novavax COVID shot for high-risk groups

The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine ... CDC statistics ...

12d

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Chicago Tribune15d

FDA approves Novavax COVID-19 shot but with unusual restrictions

The FDA had been on track to grant Novavax full approval – without restrictions ... the vaccine might be associated with some heart conditions. Another required study must assess the benefits ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results